PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
07-Nov-2019 Freeline to present data on AAV-based gene therapies for Gaucher Disease and Haemophilia A at the 61st ASH Annual Meeting Freeline
07-Nov-2019 Recent Advances in Bavarian Nordic’s Cancer Immunotherapy Platform Published in Nature Communications Bavarian Nordic
07-Nov-2019 BERGENBIO’S BEMCENTINIB MEETS PRIMARY ENDPOINT IN FIRST COHORT OF PHASE 2 NSCLC STUDY IN COMBINATION WITH KEYTRUDA® BerGenBio
07-Nov-2019 Vifor Pharma and Evotec form joint venture for early development in nephrology Vifor Pharma Group
07-Nov-2019 Medigene AG: Medigene präsentiert Poster zu Neoantigenen als Zielmolekül für zellbasierte TCR-T-Therapien auf SITC-Jahrestagung 2019 Medigene AG
07-Nov-2019 Medigene AG: Immune monitoring data from phase I/II clinical trial with DC vaccines in AML to be presented at ASH conference Medigene AG
07-Nov-2019 Autolus Therapeutics to Present New Data on Its Advanced Programmed T Cell Therapies at the 61st ASH Annual Meeting Autolus Therapeutics plc
07-Nov-2019 Summit Therapeutics to Participate in Panel Sessions at the World Antimicrobial Resistance Congress Summit Therapeutics plc
07-Nov-2019 BC Platforms Opens New Entity in Singapore to Spearhead its Asia Pacific Strategy and Hosts Launch Event in Precision Medicine BC Platforms
07-Nov-2019 PredictImmune and the Crohn’s & Colitis Foundation announce start of jointly-sponsored study to validate PredictSURE IBD™, the first prognostic test for IBD, in the US market PredictImmune
07-Nov-2019 Hikma continues strong 2019 performance and reiterates full year guidance Hikma Pharmaceuticals PLC
07-Nov-2019 Immunomedics in software project with Ideagen to streamline document reviews of cancer treatment processes t reviews of cancer treatment processes Ideagen
07-Nov-2019 Making medicines of the future: Watson-Marlow Fluid Technology Group launches sterile ReNu SU Technology cartridge assemblies for the Quantum pump Watson-Marlow Fluid Technology Group
07-Nov-2019 TOT BIOPHARM (1875.HK) Proceeded with IPO raising over HK$500 million TOT BIOPHARM International Company Limited
07-Nov-2019 BerGenBio ASA: Invitation to Third Quarter 2019 Results Presentation and Webcast BerGenBio ASA
07-Nov-2019 Targovax ASA: Third Quarter 2019 Results Targovax
06-Nov-2019 Evofem Biosciences Reports Third Quarter 2019 Financial Results and Provides Corporate Update Evofem Biosciences, Inc.
06-Nov-2019 BioMarin to Highlight Innovative Development Pipeline at R&D Day on November 14th BioMarin Pharmaceutical Inc.
06-Nov-2019 Tocagen to Report Third Quarter 2019 Financial Results and Business Updates on Tuesday, November 12 Tocagen Inc.
06-Nov-2019 Natera Reports Third Quarter 2019 Financial Results Natera, Inc.